Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03545503 · ClinicalTrials.gov registry record · Phase 4
Evaluating the Hemodynamic Effects of Ketamine Versus Etomidate During Rapid Sequence Intubation
A Phase 4 study of Intubation Complication, sponsored by South East Area Health Education Center, Wilmington, NC.
- Completed
- Registry status
- Phase 4
- Development phase
- 428
- Enrollment target
- 1
- Study location
NCT03545503: Completed Phase 4 study of Intubation Complication, sponsored by South East Area Health Education Center, Wilmington, NC.
NCT03545503 is a Phase 4 study of Intubation Complication that has completed, run by South East Area Health Education Center, Wilmington, NC. The registered enrollment target is 428 participants, below the 26,510-participant average among 10 other Intubation Complication trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03545503, a Phase 4 study of Intubation Complication, has completed, sponsored by South East Area Health Education Center, Wilmington, NC.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 428 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the hemodynamic effects of ketamine v etomidate during rapid sequence intubation (RSI) in the pre-hospital and emergency department setting.
Primary Outcome
The primary outcome of this study is to determine the change in hemodynamic response comparing systolic blood pressure pre-versus post-administration of study drug. A significant hemodynamic response is defined as a decrease in systolic blood pressure of 20% or greater between the pre versus post administered study drug.
Conditions Studied
Interventions
- DRUG Ketamine
- DRUG Etomidate
Study Locations (1)
North Carolina
- New Hanover Regional Medical Center - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 428 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2019-09-01 |
| Phase | Phase 4 |
What the finished NCT03545503 record still lists
NCT03545503 is an interventional study that assigns participants to a tested intervention. The registered 428 participants enrollment target is mid-sized for trials with a published cap, below the 26,510-participant average among 10 other Intubation Complication trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Intubation Complication appearing as the primary indexed condition, and to 2 interventions - of which Ketamine is the first listed.
NCT03545503 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03545503 about?
NCT03545503 is a clinical study titled "Evaluating the Hemodynamic Effects of Ketamine Versus Etomidate During Rapid Sequence Intubation". The purpose of this study is to compare the hemodynamic effects of ketamine v etomidate during rapid sequence intubation (RSI) in the pre-hospital and emergency department setting.
What is the current status of trial NCT03545503?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 428 participants. The study started on 2018-01-01. Estimated completion is 2019-09-01.
What conditions does trial NCT03545503 study?
This clinical trial studies the following conditions: Intubation Complication.
What interventions are being tested in trial NCT03545503?
The interventions under investigation include: Ketamine (DRUG), Etomidate (DRUG).
Who is sponsoring clinical trial NCT03545503?
This trial is sponsored by South East Area Health Education Center, Wilmington, NC, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03545503 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intubation Complication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03545503's enrollment target sits among peer trials
428 7th of 10 higher than 4 of 10 other Intubation Complication trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intubation Complication trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation
RECRUITING
-
Sonographic Assessment of Cricoid Pressure
RECRUITING · NA
-
InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS
RECRUITING · Phase 3
-
Optimizing Tracheal Intubation Outcomes and Neonatal Safety
RECRUITING · NA
-
The ED-AWARENESS-2 Trial
RECRUITING · NA
-
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05566431 · 428 participants · NA
Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics
- NCT05646316 · 428 participants · Phase 3
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
- NCT05797610 · 428 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
- NCT06073626 · 428 participants · NA
Addressing Genomic Disparities in Cancer Survivors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI